Key Record Dates
ClinicalTrials.gov Identifier: | NCT04808362 |
---|---|
Brief Title: | Phase 1/2 Study to Evaluate Safety, PK and Efficacy of the MYC-Inhibitor OMO-103 in Solid Tumours (MYCure) |
First Submitted : | March 16, 2021 |
First Submitted that Met QC Criteria : | March 18, 2021 |
First Posted : | March 22, 2021 |
Results First Submitted : | October 16, 2023 |
Results First Submitted that Met QC Criteria : | April 23, 2024 |
Results First Posted : | April 25, 2024 |
Last Update Submitted that Met QC Criteria : | April 23, 2024 |
Last Update Posted : | April 25, 2024 |